173 related articles for article (PubMed ID: 16445003)
1. The incidence of recurrence and hypothyroidism after radioiodine treatment in patients with hyperthyroidism in Trakya, a mild iodine deficiency area, during the period 1991-2003.
Ustun F; Yuksel M; Durmus-Altun G; Kaya M; Cermik TF; Sarikaya A; Berkarda S
Ann Nucl Med; 2005 Dec; 19(8):737-42. PubMed ID: 16445003
[TBL] [Abstract][Full Text] [Related]
2. Radioiodine treatment of hyperthyroidism-prognostic factors for outcome.
Allahabadia A; Daykin J; Sheppard MC; Gough SC; Franklyn JA
J Clin Endocrinol Metab; 2001 Aug; 86(8):3611-7. PubMed ID: 11502786
[TBL] [Abstract][Full Text] [Related]
3. Long-term follow-up study of radioiodine treatment of hyperthyroidism.
Metso S; Jaatinen P; Huhtala H; Luukkaala T; Oksala H; Salmi J
Clin Endocrinol (Oxf); 2004 Nov; 61(5):641-8. PubMed ID: 15521969
[TBL] [Abstract][Full Text] [Related]
4. Radioiodine treatment of hyperthyroidism: prognostic factors affecting outcome.
Erem C; Kandemir N; Hacihasanoglu A; Ersöz HO; Ukinc K; Kocak M
Endocrine; 2004 Oct; 25(1):55-60. PubMed ID: 15545707
[TBL] [Abstract][Full Text] [Related]
5. [Radioiodine treatment of hyperthyroidism using a simplified dosimetric approach. Clinical results].
Giovanella L; De Palma D; Ceriani L; Vanoli P; Garancini S; Tordiglione M; Tarolo GL
Radiol Med; 2000 Dec; 100(6):480-3. PubMed ID: 11307510
[TBL] [Abstract][Full Text] [Related]
6. [Treatment of hyperthyroidism caused by Graves' disease or toxic multinodular goitre by radioiodine: over 80% cure retrospectively after one calculated dose].
Bakker SC; Zanin DE; Zweers EJ
Ned Tijdschr Geneeskd; 2002 Sep; 146(39):1837-41. PubMed ID: 12382370
[TBL] [Abstract][Full Text] [Related]
7. Radioiodine therapy compared in patients with toxic nodular or Graves' hyperthyroidism.
Franklyn JA; Daykin J; Holder R; Sheppard MC
QJM; 1995 Mar; 88(3):175-80. PubMed ID: 7767667
[TBL] [Abstract][Full Text] [Related]
8. Prediction of cure and risk of hypothyroidism in patients receiving 131I for hyperthyroidism.
Boelaert K; Syed AA; Manji N; Sheppard MC; Holder RL; Gough SC; Franklyn JA
Clin Endocrinol (Oxf); 2009 Jan; 70(1):129-38. PubMed ID: 18462261
[TBL] [Abstract][Full Text] [Related]
9. What influences early hypothyroidism after radioiodine treatment for Graves' hyperthyroidism?
Vijayakumar V; Ali S; Nishino T; Nusynowitz M
Clin Nucl Med; 2006 Nov; 31(11):688-9. PubMed ID: 17053385
[TBL] [Abstract][Full Text] [Related]
10. The predictive role of 24h RAIU with respect to the outcome of low fixed dose radioiodine therapy in patients with diffuse toxic goiter.
Damle N; Bal C; Kumar P; Reddy R; Virkar D
Hormones (Athens); 2012; 11(4):451-7. PubMed ID: 23422768
[TBL] [Abstract][Full Text] [Related]
11. Effectiveness of radioiodine (131-I) as definitive therapy in patients with autoimmune and non-autoimmune hyperthyroidism.
Tarantini B; Ciuoli C; Di Cairano G; Guarino E; Mazzucato P; Montanaro A; Burroni L; Vattimo AG; Pacini F
J Endocrinol Invest; 2006; 29(7):594-8. PubMed ID: 16957406
[TBL] [Abstract][Full Text] [Related]
12. Incidence of Hypothyreoidism after Radioactive Iodine-I131 Treatment in Dependance of Hyperthyreoidism Etiology and Therapy Dose.
Beslic N; Licina S; Sadija A; Milardovic R
Med Arch; 2017 Aug; 71(4):270-273. PubMed ID: 28974848
[TBL] [Abstract][Full Text] [Related]
13. Cohort study on radioactive iodine-induced hypothyroidism: implications for Graves' ophthalmopathy and optimal timing for thyroid hormone assessment.
Stan MN; Durski JM; Brito JP; Bhagra S; Thapa P; Bahn RS
Thyroid; 2013 May; 23(5):620-5. PubMed ID: 23205939
[TBL] [Abstract][Full Text] [Related]
14. Use of a dosimetry-based RAI protocol for treatment of benign hyperthyroidism optimises response while minimising exposure to ionising radiation.
Miller C; Al-Jabri A; O'Murchada L; Mustafa M; Cooke J; Phelan N; Healy ML
Clin Endocrinol (Oxf); 2024 Jun; 100(6):585-592. PubMed ID: 38567706
[TBL] [Abstract][Full Text] [Related]
15. Clinical outcome after standardized versus dosimetric radioiodine treatment of hyperthyroidism: an equivalence study.
Kok SW; Smit JW; de Craen AJ; Goslings BM; van Eck-Smit BL; Romijn JA
Nucl Med Commun; 2000 Nov; 21(11):1071-8. PubMed ID: 11192714
[TBL] [Abstract][Full Text] [Related]
16. [Results of radioiodine therapy of manifest hyperthyroidism and autonomous struma with euthyroidism].
Berding G; Schicha H
Nuklearmedizin; 1990 Aug; 29(4):158-65. PubMed ID: 2216811
[TBL] [Abstract][Full Text] [Related]
17. [Short-term results of treatment with 131I in patients with multinodular goiter: effect of the associated degree of hyperthyroidism and other variables].
Boj Carceller D; Liévano Segundo P; Navarro Beltrán P; Sanz París A; de Castro Hernández P; Monreal Villanueva M; Abós Olivares D
Rev Esp Med Nucl; 2011; 30(3):156-61. PubMed ID: 21481495
[TBL] [Abstract][Full Text] [Related]
18. Functional results of radioiodine therapy with a 300-Gy absorbed dose in Graves' disease.
Willemsen UF; Knesewitsch P; Kreisig T; Pickardt CR; Kirsch CM
Eur J Nucl Med; 1993 Nov; 20(11):1051-5. PubMed ID: 8287872
[TBL] [Abstract][Full Text] [Related]
19. Utility of outpatient fractionated radioiodine therapy for Graves disease involving a large goiter measuring more than 100 mL in volume.
Mizokami T; Hamada K; Maruta T; Higashi K; Tajiri J
Endocr J; 2021 Sep; 68(9):1117-1125. PubMed ID: 33980774
[TBL] [Abstract][Full Text] [Related]
20. The feasibility of low-dose oral lithium therapy and its effect on thyroidal radioiodine uptake, retention, and hormonal parameters in various subcategories of hyperthyroid patients: a pilot study.
Chouhan A; Abhyankar A; Basu S
Nucl Med Commun; 2016 Jan; 37(1):74-8. PubMed ID: 26465804
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]